Recovery method of serotypable character in non serotypable pseudomonas aeruginosa strains;Méthode de récupération du caractère sérotypable chez les souches initialement non sérotypables de Pseudomonas aeruginosa

Pathologie Biologie

Volumn 52, Issue 1, 2004, Pages 33-38

  Soler, C P ^a   Gidenne, S ^a   Saint blancard, P ^b   Kerleguer, A ^a   Gerome, P ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b PERCY MILITARY HOSPITAL   (France)

Author keywords

Alginate; Pseudomonas aeruginosa; Serotype; Specific lipopolysaccharide

Indexed keywords

ALGINIC ACID; AMIKACIN; BACTERIUM LIPOPOLYSACCHARIDE; GLUCOSE; LIPOPOLYSACCHARIDE; O ANTIGEN; RHAMNOSE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEROTYPING;

EID: 0842348218     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2003.09.013     Document Type: Article

References (32)

1. Schwartz D. Méthodes statistiques à l'usage des médecins et des biologistes. 4e édition. Médecines Sciences. Flammarion. Paris.
2. Rivera M., Hancock R., Mac Groarty E. Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa. J. Bacteriol. 170:1988;512-521.
3. Rivera M., Mac Groarty E. Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa. J. Bacteriol. 171:1989;2244-2248.
4. Habs I. Untersuchungen ber die O-antigene von Pseudomonas aeruginosa. Zbl Hyg infktioskr. 144:1957;218-228.
5. Liu P., Wang S. Three new major somatic antigens of Pseudomonas aeruginosa. J. Clin. Microbiol. 28:1990;922-925.
6. Zielinski N., Chakrabarty A., Berry A. Characterization and regulation of the Pseudomonas aeruginosa algC gene encoding phosphomannomutase. J. Biol. Chem. 266:1991;9754-9763.
7. Deretic V., Gill J., Chakrabarty A. Gene algD coding for GDPmannose dehydrogenase is transcriptioally actived in mucoid Pseudomonas aeruginosa. J. Bacteriol. 169:1987;351-358.
8. Fujiwara S., Zielinski N., Chakrabarty A. Enhancer-like activity of AlgR1-binding site in alginate gene activation: positional, orientational and sequence specificity. J. Bacteriol. 175:1993;5452-5459.
9. Fegan M., Davis G., Fuerst J. Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis. J. Clin. Microbiol. 28:1990;1143-1146.
10. Wozniak D., Ohman D. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB and algD reveals a hierarchy of alginate gene expression, which is modulated by algT. J. Bacteriol. 176:1994;6007-6014.
11. Lazdunski A. Les facteurs de virulence de Pseudomonas aeruginosa et leur régulation. Méd. Mal. Infect. 28:(spécial):1998;109-118.
12. Xie Z., Hershberger C., Chakrabarty A. Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA. J. Bacteriol. 178:1996;4990-4996.
13. Deretic V., Konyecsni W., Misra T. The algR gene, which regulates mucoidy in Pseudomonas aeruginosa, belongs to a class of environmentally responsive genes. J. Bacteriol. 171:1987;1278-1283.
14. Schurr M., Yu H., Boucher J., Deretic V. Multiple promoters and induction by heat shock of the gene encoding the alternative sigma factor AlgU that controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. J. Bacteriol. 177:1995;5670-5679.
15. Deretic V., Govan J., Martin D. Mucoid Pseudomonas aeruginosa in cystic fibrosis: mutations in the muc loci affect transcription of the algR and algD genes in response to environmental stimuli. Mol. Microbiol. 4:1990;189-196.
16. Schurr M., Deretic V. Microbial pathogenesis in cystic fibrosis: co-ordinate regulation of heat-shock response and conversion to mucoidy in Pseudomonas aeruginosa. Mol. Microbiol. 24:1997;411-420.
17. Mathee K., Ohman D. Posttranslational control of the algT (algU) encoded 22 for expression of the alginate regulon in Pseudomonas aeruginosa and localisation of its antagonist proteins MucA and MucB (AlgN). J. Bacteriol. 179:1997;3711-3720.
18. De Vault J., Kimbara K., Chakrabarty A. Pulmonary dehydratation and infection in cystic fibrosis: evidence that ethanol activates alginate gene expression and induction of mucoidy in Pseudomonas aeruginosa. Mol. Microbiol. 4:1990;737-745.
19. Berry A., De Vault J., Chakabarty A. High osmollarity is a signal for enhanced algD transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains. J. Bacteriol. 171:1989;2312-2317.
20. Bayer A., Tu J., Nast C., Speert D.P. Oxygen-dependent up-regulation of mucoid exopolysaccharide production in Pseudomonas aeruginosa. Infect. Immun. 58:1990;1344-1349.
21. De Vries C., Ohman D. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J. Bacteriol. 176:1994;6677-6687.
22. Matjan V., Hybenova D. Inhibition of Pseudomonas aeruginosa alginate expression by subinhibitory concentrations of antibiotics. Folia Microbiol. 41:1996;61-64.
23. Ichimiya T., Yamasaki T., Nasu N. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J. Antimicrob. Chemother. 34:1994;331-341.
24. Gérôme P., Teyssou R., Grandadam M., Hervé V., Chapalain J.C., Ainaud P., Le Vagueresse R., Buisson Y. Which marker to detect and characterize a Pseudomonas aeruginosa outbreak? R.I.C.A.I. 283/P18:1997.
25. Lanyi B., Lantos J. Antigenic changes in Pseudomonas aeruginosa in vivo and after lysogenization in vitro. Acta Microbiol. Acad. Sci. Hung. 23:1976;337-351.
26. Liu P.V. Changes in somatic antigens of Pseudomonas aeruginosa induced by bacteriophages. J. Infect. Dis. 119:1969;237-246.
27. Bergmans D., Bonten M., van Tiel F., Gaillard C., London N., van der Geest S., de Leeuw P., Stobberingh E. Value of phenotyping methods as initial screening of Pseudomonas aeruginosa in epidemiologic studies. Infection. 25:1997;350-354.
28. Pirnay J.P., De Vos D., Cochez C., Bilocq F., Pirson J., Struelens M., Duinslaeger L., Cornelis P., Zizi M., Vanderkelen A. Molecular epidemiology of Pseudomonsas aeruginosa colnization in a burn unit: persistence of multidrug-resistant clone and a silver sulfadiazine-resistant clone. J. Clin. Microbiol. 41:2003;1192-1202.
29. Talarmin A., Dubrous P., Gérôme P., Buisson Y. Study of Pseudomonas aeruginosa serotype O12 isolates with a common antibiotic pattern. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;459-464.
30. Millesimo M., De Intinis G., Chirillo M.G., Musso T., Savoia D. Pseudomonas aeruginosa clinical isolates; serotypes, resistance phenotypes and plasmid profiles. Eur. J. Epidemiol. 12:1996;123-129.
31. Knirel Y. Polysaccharide antigens of Pseudomonas aeruginosa. Crit. Rev. Microbiol. 17:1990;273-300.
32. Fomsgaard A., Kronborg G., Hoiby N. Antibodies from chronically infected cystic fibrosis patients react with lipopolysaccharides extracted by new micromethods from all serotypes of Pseudomonas aeruginosa. APMIS. 101:1993;101-112.